Search research articles
Contact Us
Filters
Showing results (171-180 of 1,143) with videos related to
Page
of 115
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1999
The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53
C Gobert, A Skladanowski, A K Larsen
The Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry
|
May 2, 2003
FRONTLINE--the schizophrenic person and the benefits of the psychotherapies--seeking a PORT in the storm
Ann-Louise S Silver, Tor K Larsen
Scandinavian Journal of Thoracic and Cardiovascular Surgery
|
January 1, 1983
Perforation and rupture of the esophagus
K Larsen, B Skov Jensen, F Axelsen
Transactions - American Society for Artificial Internal Organs
|
January 1, 1984
Enzymatic extracorporeal deheparinization: effects of sub-chronic exposure to heparin fragments
A K Larsen, S Hetelekidis, R Langer
Biochemical Pharmacology
|
January 31, 1995
Aurintricarboxylic acid, a putative inhibitor of apoptosis, is a potent inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells
Y Benchokroun, J Couprie, A K Larsen
Cell Cycle (Georgetown, Tex.)
|
June 28, 2008
The influence of G(2) arrest abrogation on the long-term cytotoxicity of different genotoxic lesions
Przemyslaw Bozko, Annette K Larsen, Andrzej Skladanowski
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment
|
March 30, 2010
Estimated intake of benzoic and sorbic acids in Denmark
T Leth, T Christensen, I K Larsen
Archives of Orthopaedic and Trauma Surgery
|
January 1, 1989
Functional results following fractures of the proximal humerus. A controlled clinical study comparing two periods of immobilization
B Kristiansen, P Angermann, T K Larsen
Acta Psychiatrica Scandinavica
|
October 1, 1987
The thyrotropin response to thyrotropin-releasing hormone as a biological marker of suicidal risk in depressive patients
A Kørner, C Kirkegaard, J K Larsen
Pharmacology & Therapeutics
|
July 31, 2003
Catalytic topoisomerase II inhibitors in cancer therapy
Annette K Larsen, Alexandre E Escargueil, Andrzej Skladanowski
Page
of 115
Search research articles
Search
Showing results (171-180 of 1,143) with videos related to
Sort By:
Page
of 115
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1999
The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53
C Gobert, A Skladanowski, A K Larsen
The Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry
|
May 2, 2003
FRONTLINE--the schizophrenic person and the benefits of the psychotherapies--seeking a PORT in the storm
Ann-Louise S Silver, Tor K Larsen
Scandinavian Journal of Thoracic and Cardiovascular Surgery
|
January 1, 1983
Perforation and rupture of the esophagus
K Larsen, B Skov Jensen, F Axelsen
Transactions - American Society for Artificial Internal Organs
|
January 1, 1984
Enzymatic extracorporeal deheparinization: effects of sub-chronic exposure to heparin fragments
A K Larsen, S Hetelekidis, R Langer
Biochemical Pharmacology
|
January 31, 1995
Aurintricarboxylic acid, a putative inhibitor of apoptosis, is a potent inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells
Y Benchokroun, J Couprie, A K Larsen
Cell Cycle (Georgetown, Tex.)
|
June 28, 2008
The influence of G(2) arrest abrogation on the long-term cytotoxicity of different genotoxic lesions
Przemyslaw Bozko, Annette K Larsen, Andrzej Skladanowski
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment
|
March 30, 2010
Estimated intake of benzoic and sorbic acids in Denmark
T Leth, T Christensen, I K Larsen
Archives of Orthopaedic and Trauma Surgery
|
January 1, 1989
Functional results following fractures of the proximal humerus. A controlled clinical study comparing two periods of immobilization
B Kristiansen, P Angermann, T K Larsen
Acta Psychiatrica Scandinavica
|
October 1, 1987
The thyrotropin response to thyrotropin-releasing hormone as a biological marker of suicidal risk in depressive patients
A Kørner, C Kirkegaard, J K Larsen
Pharmacology & Therapeutics
|
July 31, 2003
Catalytic topoisomerase II inhibitors in cancer therapy
Annette K Larsen, Alexandre E Escargueil, Andrzej Skladanowski
Page
of 115